vix.ing · top · new · best · stats · spec

The evolving HIV epidemic in Ontario, Canada: A retrospective analysis of new HIV diagnoses to identify subpopulations with persistent risk of HIV transmission

2025/03/18 by Abigail Kroch, David Gogolishvili, Kristen O’Brien +8
Immunology and Microbiology · Medicine · #HIV Research and Treatment #HIV, Drug Use, Sexual Risk #HIV/AIDS Research and Interventions

paper · pdf · doi:10.17269/s41997-025-00997-8

crossref issued 2025/03/18 · crossref published 2025/03/18 · crossref published-online 2025/03/18 · openalex publication_date 2025/03/18 · crossref created 2025/03/18 · openalex created_date 2025/10/10 · crossref published-print 2025/12/01 · crossref deposited 2025/12/30 · crossref indexed 2026/07/24 · openalex updated_date 2026/08/01

Abstract

OBJECTIVE: The objective of this study was to characterize new HIV diagnoses in key Ontario cities, in order to understand current drivers of continued HIV transmission to inform HIV testing and prevention efforts. METHODS: Chart reviews were carried out at four clinical sites in Ontario, Canada. The study population included individuals who were diagnosed with HIV in Ottawa, Hamilton, and Toronto between January 1, 2018, and December 31, 2020, and had no previous evidence of HIV documented. RESULTS: The total number of persons in this analysis was 359, from Toronto (n = 201), Ottawa (n = 88), and Hamilton (n = 70). More than half of the diagnoses were among those who immigrated to Canada, and many were diagnosed (11%) during the year they arrived. Many participants experienced a late diagnosis (43.2%), and while 116 (32.3%) had HIV testing history in Ontario, 155 did not (43.2%). Many participants were men who have sex with men (MSM) and had a previously recorded diagnosis of gonorrhea or chlamydia (n = 27; 7.5%) or syphilis (n = 39; 10.9%). Among women and heterosexual men, a diagnosis of hepatitis C (n = 18; 5.0%) appeared to signal a risk of HIV diagnosis. CONCLUSION: These data show that HIV testing and prevention strategies should be targeted to (1) MSM with a history of syphilis, gonorrhea, or chlamydia; (2) heterosexual men and women with a history of hepatitis C; and (3) immigrants within the first 5 years of migration. To address the evolving epidemic, it will be necessary to employ targeted HIV screening and prevention measures.

Related